LEVET SOLUTION

Levet is indicated as monotherapy for the treatment of partial onset seizures with or without secondary generalization in patients from 16 years of age with newly diagnosed epilepsy. Levet is indicated in combination: – in the treatment of partial seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy. – in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. – in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with generalized idiopathic epilepsy.